Investigation of the Effect of 5-Aza-2'-Deoxycytidine on p15INK4, p16INK4, p18INK4, and p19INK4 Genes Expression, Cell Growth Inhibition, and Apoptosis Induction in Hepatocellular Carcinoma PLC/PRF/5 Cell Line
Related Experiment Video
Updated: Dec 5, 2025
Masumeh Sanaei1, Fraidoon Kavoosi1, Ali Ghasemi2
1Research Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Fars Province, Iran.
Background:
Cyclin-dependent kinases (CDKs) are the key regulators of cell-cycle transitions and characterized by needing a separate subunit, a cyclin, which provides domains essential for enzymatic activity. The activities of cyclin-CDK complexes are controlled by a group of molecules that inhibit CDK activity and CDK inhibitors (CKIs). Cancer often exhibits an aberrant CpG methylation of promoter regions of tumor suppressor genes such as CKIs. Treatment with the DNA demethylating agents, such as 5-aza-2'-deoxycytidine (5-Aza-CdR), can restore and upregulate CKIs. Previously, we reported the effect of 5-Aza-CdR and genistein on DNA methyltransferase (DNMTs) in hepatocellular carcinoma (HCC). The aim of the present study was to evaluate the effect of 5-Aza-CdR on p15INK4, p16INK4, p18INK4, and p19INK4 genes expression, cell growth inhibition, and apoptosis induction in HCC PLC/PRF/5 cell line.
Materials And Methods:
The effect of 5-Aza-CdR on the cell growth of PLC/PRF/5 cells, genes expression, and apoptosis induction were assessed by 3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide assay, real-time quantitative reverse transcription-polymerase chain reaction analysis, and flow cytometry, respectively.
Results:
5-Aza-CdR (0, 1, 5, 10, 25, and 50 μM) inhibited PLC/PRF/5 cell growth at different periods significantly. This compound induced apoptosis and reactivated p15INK4, p16INK4, p18INK4, and p19INK4 genes expression at a concentration of 5 μM significantly.
Conclusion:
5-Aza-CdR can inhibit cell viability and induce apoptosis by epigenetic reactivation of p15INK4, p16INK4, p18INK4, and p19INK4 genes in HCC PLC/PRF/5.
Insights
The DNA demethylating agent 5-aza-2'-deoxycytidine (5-Aza-CdR) effectively inhibits hepatocellular carcinoma (HCC) cell growth. It also induces apoptosis and reactivates key tumor suppressor genes, p15INK4, p16INK4, p18INK4, and p19INK4, through epigenetic mechanisms.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Cyclin-dependent kinases (CDKs) regulate cell-cycle transitions and are controlled by cyclin-dependent kinase inhibitors (CKIs).
- Aberrant CpG methylation of tumor suppressor genes, including CKIs, is common in cancer.
- DNA demethylating agents like 5-aza-2 -deoxycytidine (5-Aza-CdR) can restore CKI expression.
Purpose of the Study:
- To evaluate the effect of 5-Aza-CdR on the expression of p15INK4, p16INK4, p18INK4, and p19INK4 genes in hepatocellular carcinoma (HCC) PLC/PRF/5 cells.
- To assess the impact of 5-Aza-CdR on HCC cell growth inhibition and apoptosis induction.
Main Methods:
- Cell viability was assessed using the 3- [4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide assay.
- Gene expression levels of p15INK4, p16INK4, p18INK4, and p19INK4 were quantified using real-time quantitative reverse transcription-polymerase chain reaction.
- Apoptosis induction was measured by flow cytometry.
Main Results:
- 5-Aza-CdR significantly inhibited PLC/PRF/5 cell growth across various concentrations and time points.
- A concentration of 5 μM 5-Aza-CdR significantly induced apoptosis in HCC cells.
- 5-Aza-CdR treatment reactivated the expression of p15INK4, p16INK4, p18INK4, and p19INK4 genes.
Conclusions:
- 5-Aza-CdR demonstrates potent anti-cancer effects in HCC by inhibiting cell viability.
- The compound induces apoptosis and reactivates silenced tumor suppressor genes epigenetically.
- Epigenetic reactivation of p15INK4, p16INK4, p18INK4, and p19INK4 contributes to the anti-cancer activity of 5-Aza-CdR in HCC.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle


